Pfizer slashes prices as most pharma makers raise prices in new year
Pfizer bucks the trend with as high as 98.5% price cuts.
Read more
 
FDA clears first-in-class migraine drug
Approval of Ubrelvy follows several new migraine drugs.
Read more
 
EDITOR'S PICK
New CMS rule will confuse patients, group says
Hospitals sue over drug price disclosure rule.
Read more